The American College of Cardiology (ACC) will become an official co-sponsor of Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation (CRF).
The symposium will become known as “Transcatheter Cardiovascular Therapeutics (TCT) In Partnership with ACC.”
CRF and ACC have had an existing partnership agreement since 2008, whereby CRF helps to coordinate the interventional content at the Innovations in Interventions (i2) Summit at ACC’s annual scientific sessions.
“The enhanced partnership will involve sharing of content and distribution of educational materials,” the societies said in a press release. In addition, co-sponsorship of continuing medical education (CME) awarded for meeting attendance and participation will be “explored.”
The two organizations will form a physician-led “Collaborative Council” comprised of senior physician leaders from both organizations. The council will meet regularly to review progress toward established objectives and set the direction of the affiliation.
According to the societies, further national and international educational programs and scientific efforts will be explored jointly. ACC and CRF staff also will meet regularly to share best practices, consider joint procurement of vendors to provide services and products on behalf of the collaboration, consider reciprocal exposition space at annual meetings, and explore collaboration around industry training programs.
“CRF’s prior partnership in the i2 Summit, held in conjunction with the ACC annual scientific session, demonstrated there is a growing universality and need for educational collaboration,” said David J. Holmes, MD, president-elect of the ACC.